Why is Mankind Pharma falling/rising?

As of 09-Sep, Mankind Pharma Ltd's stock price is currently at 2,593.35, reflecting an increase of 14.75, or 0.57%. The stock has shown a positive performance today, gaining 1.65% over the last two days and trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. However, there is a notable decline in investor participation, with delivery volume falling by 69.4% compared to the 5-day average. Despite this, the company demonstrates strong fundamentals, including a high return on equity of 17.21%, a low debt-to-equity ratio, and healthy long-term growth rates in net sales and operating profit. Additionally, the stock has outperformed the broader market, generating a 7.57% return over the past year while the market has seen negative returns.
In the broader market context, Mankind Pharma's short-term return of 1.90% over the past week exceeds the Sensex's return of 1.18%, indicating a stronger performance relative to the benchmark. This trend is further supported by the company's high institutional holdings, which suggest confidence from investors with greater analytical resources. While the stock has faced challenges with declining delivery volumes, its overall performance and management efficiency contribute positively to its recent price movement.